Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 1.6% in the afternoon session after the company announced a positive update on a clinical study for its Control-IQ ...
Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi ...
Users of Tandem Diabetes Care’s insulin pumps now have a new way to monitor the pumps’ data and manage their equipment. After being unveiled during the American Diabetes Association’s annual ...
Helping toddlers manage their Type 1 diabetes—typically a difficult task, due to their constant growth and development, not to mention fussiness—may now be a bit easier. The FDA has expanded its ...
StockStory.org on MSN
Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...
In initiating coverage on Tandem Diabetes, we peg its fair value estimate at $34 per share. Despite the solid commercial adoption of Tandem’s t:slim pump franchise, we think the firm has yet to dig an ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations , with sales up 2.2% year on year to $249.3 million. Its GAAP loss ...
Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by the strength of t:slim X2 based on Control-IQ technology and new product launches. The ongoing progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results